Pure. Precise. Exceptional, for Patients.
Exceptional, for Patients.
Welcome to WAVE Life Sciences. We are a preclinical genetic medicine company focused on advancing stereopure nucleic acid therapeutics that precisely target the underlying cause of rare diseases, with a goal of delivering exceptional treatment options for patients.
Our Vision to Get There
Our proprietary chemistry eliminates the incredibly complex chemical mixtures that are inherent in all other nucleic acid therapies and can lead to suboptimal efficacy and increased risk and safety concerns. With this completely new approach, we can precisely control how our nucleic acid medicines target disease.
From Potential to Reality
Nucleic acid therapeutics hold the potential to treat numerous serious, often devastating genetic diseases. But various challenges have hindered rapid progress in the field. We are developing genetic medicines designed to overcome these challenges. Our preclinical pipeline spans multiple oligonucleotide modalities, potentially enabling us to address a broad range of rare disorders.
What it Means for Patients
By more effectively targeting underlying disease biology, we believe we will be able to maximize therapeutic effect while minimizing the potential for side effects and safety risks. The result: optimally designed genetic medicines that work better for patients.